Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Methods and Compositions for Diagnosing AIDS and Other Diseases and Conditions Involving Immune System Activation

  • Read more about Methods and Compositions for Diagnosing AIDS and Other Diseases and Conditions Involving Immune System Activation
US Application 60/564,588
Filed on 2004-04-23

Fragments Containing the Receptor-Binding Domain for SARS-CoV S Glycoprotein as Vaccines and Inhibitors

  • Read more about Fragments Containing the Receptor-Binding Domain for SARS-CoV S Glycoprotein as Vaccines and Inhibitors
US Application 60/524,642
Filed on 2003-11-25

Stem Cell Factor (SCF) Stimulates Neural Stem Cell Migration To Sites Of Brain And Spinal Cord Injury

  • Read more about Stem Cell Factor (SCF) Stimulates Neural Stem Cell Migration To Sites Of Brain And Spinal Cord Injury
US Application 60/563,397
Filed on 2004-04-19

Peptide Inhibitors of HIV-1 Integrase Useful for the Treatment Of Retroviral Infection and HIV

  • Read more about Peptide Inhibitors of HIV-1 Integrase Useful for the Treatment Of Retroviral Infection and HIV
US Application 60/534,378
Filed on 2004-01-06

Methods for the Production of Biliverdin

  • Read more about Methods for the Production of Biliverdin
US Application 60/554,369
Filed on 2004-03-19

Cellular and Viral Inactivation

  • Read more about Cellular and Viral Inactivation
US Application 60/555,268
Filed on 2004-03-22

Stem Cell Factor (SCF) Stimulates Neural Stem Cell Migration To Sites Of Brain And Spinal Cord Injury

  • Read more about Stem Cell Factor (SCF) Stimulates Neural Stem Cell Migration To Sites Of Brain And Spinal Cord Injury
US Application 60/525,760
Filed on 2003-11-26

Glycoproteins tagged with Galactose at the free N-acetylglucosamine Moieties and Methods of Synthesis thereof

  • Read more about Glycoproteins tagged with Galactose at the free N-acetylglucosamine Moieties and Methods of Synthesis thereof
US Application 60/523,112
Filed on 2003-11-19

Method and Composition For Inhibition of Metastatic Melanoma

  • Read more about Method and Composition For Inhibition of Metastatic Melanoma
US Application 60/531,876
Filed on 2003-12-22

Methods Of Inhibiting Metastasis Or Growth Of A Tumor Cell

  • Read more about Methods Of Inhibiting Metastasis Or Growth Of A Tumor Cell
US Application 60/511,581
Filed on 2003-10-15

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 169
  • Page 170
  • Page 171
  • Page 172
  • Page 173
  • Page 174
  • Page 175
  • Page 176
  • Page 177
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health